We are live on ! Find out more
PCH

Polar Capital Holdings Portfolio holdings

AUM $42.4B
1-Year Est. Return 181.11%
This Fund
S&P 500
This Quarter Est. Return
+15.4%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
AUM
$17.9B
AUM Growth
-$3.08B
Cap. Flow
-$132M
Cap. Flow %
-0.74%
Top 10 Hldgs %
31.19%
Holding
330
New
43
Increased
82
Reduced
112
Closed
34

Top Buys

Rank Stock Value
1
GEV icon
GE Vernova
GEV
+$164M
2
MRVL icon
Marvell Technology
MRVL
+$135M
3
GLW icon
Corning
GLW
+$124M
4
CLS icon
Celestica
CLS
+$112M
5
DDOG icon
Datadog
DDOG
+$110M

Sector Composition

Rank Sector Weight
1 Technology 42.96%
2 Financials 17.48%
3 Healthcare 15.13%
4 Communication Services 13.07%
5 Consumer Discretionary 6.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MMYT icon
51
MakeMyTrip
MMYT
$4.75B
$102M 0.57%
910,314
-77,726
-8% -$8.33M
HUBS icon
52
HubSpot
HUBS
$12.5B
$102M 0.57%
146,155
+37,824
+35% +$24.3M
RGA icon
53
Reinsurance Group of America
RGA
$16.2B
$101M 0.56%
471,000
CRDO icon
54
Credo Technology Group
CRDO
$28.2B
$97.5M 0.55%
1,451,084
+1,150,084
+382% +$57.1M
RYAN icon
55
Ryan Specialty Holdings
RYAN
$4.65B
$97.2M 0.54%
1,515,000
ARM icon
56
Arm
ARM
$255B
$94.2M 0.53%
763,939
+77,420
+11% +$10.9M
APP icon
57
Applovin
APP
$112B
$93M 0.52%
287,039
-137,314
-32% -$34.7M
PANW icon
58
Palo Alto Networks
PANW
$306B
$90.6M 0.51%
497,776
-102,328
-17% -$19.3M
RYTM icon
59
Rhythm Pharmaceuticals
RYTM
$7.21B
$84M 0.47%
1,500,000
PCVX icon
60
Vaxcyte
PCVX
$8.85B
$79.7M 0.45%
973,645
-22,134
-2% -$2.2M
NUVL
61
DELISTED
Nuvalent
NUVL
$74.1M 0.41%
946,723
+584,223
+161% +$54.6M
LLY icon
62
Eli Lilly
LLY
$1.01T
$73.2M 0.41%
94,843
-3,092
-3% -$2.56M
ALNY icon
63
Alnylam Pharmaceuticals
ALNY
$33.5B
$72.9M 0.41%
310,000
AMGN icon
64
Amgen
AMGN
$206B
$72.9M 0.41%
279,826
-102,112
-27% -$30.3M
SNOW icon
65
Snowflake
SNOW
$117B
$72M 0.4%
+465,973
New +$65.6M
MRUS
66
DELISTED
Merus
MRUS
$71.7M 0.4%
1,706,238
+439,186
+35% +$21.1M
GLOB icon
67
Globant
GLOB
$1.63B
$71M 0.4%
330,897
+14,730
+5% +$3.21M
V icon
68
Visa
V
$701B
$70.6M 0.39%
223,439
+13,117
+6% +$3.94M
VRTX icon
69
Vertex Pharmaceuticals
VRTX
$132B
$70.5M 0.39%
175,000
NVMI
70
Nova
NVMI
$11.8B
$69.8M 0.39%
354,302
+295,691
+504% +$56.8M
TCOM icon
71
Trip.com Group
TCOM
$24.6B
$69.5M 0.39%
1,012,840
+275,629
+37% +$18.2M
TTD icon
72
Trade Desk
TTD
$7.03B
$68.2M 0.38%
580,050
-509,565
-47% -$63M
GMED icon
73
Globus Medical
GMED
$9.96B
$63.8M 0.36%
+770,913
New +$60.8M
AMD icon
74
Advanced Micro Devices
AMD
$805B
$62.9M 0.35%
520,863
-2,119,466
-80% -$305M
SUPN icon
75
Supernus Pharmaceuticals
SUPN
$2.41B
$61M 0.34%
1,687,930
-250,000
-13% -$8.8M

Similar funds

Polar Capital Holdings's Q4 2024 Portfolio in Review

As of Q4 2024, Polar Capital Holdings held 330 positions worth $17.9B, down 15% from $21B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Polar Capital Holdings's Q4 2024 filing shows 43 new, 82 increased, 112 reduced and 34 closed positions. Its largest new stake was Corning: 2,614,751 shares worth $124M. The largest sale was Advanced Micro Devices, an estimated $305M.

By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.

  • Polar Capital Holdings's largest Q4 2024 buy was Corning: 2,614,751 shares worth $124M.
  • Polar Capital Holdings added most to GE Vernova in Q4 2024, an estimated $164M increase.
  • Polar Capital Holdings's biggest Q4 2024 reduction was Advanced Micro Devices, cutting an estimated $305M.
  • Polar Capital Holdings fully exited Teradyne in Q4 2024, selling an estimated $130M.
  • Polar Capital Holdings's ten largest holdings make up 31% of its $17.9B portfolio in Q4 2024.
  • Polar Capital Holdings opened 43 new positions and closed 34 in Q4 2024.
  • Polar Capital Holdings's portfolio value fell 15% quarter-over-quarter to $17.9B.

Based on Polar Capital Holdings's 13F filing for Q4 2024, filed 14 Feb 2025.